Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
Reading miRNAs for Clinical Meaning
Single miRNAs Don’t Say Much, but They May Become Eloquent Biomarkers if We Take Their Testimony in Context
Sorting Out the CRISPR Patent Case
Sounds of Science Podcast
Good Assays for Bad Immunogenicity
Avoid “Bad” Immunogenicity by Using Assays That Are More Sensitive and Can Adapt to Increasingly Complex and Specialized Drugs
VIDEO: GENESIS™ Precision Genome Editing with CRISPR and rAAV
Horizon Discovery offers both nuclease based gene editing using CRISPR technology and homologous recombination based editing using rAAV.
Horizon Discovery's GENESIS™ platform offers gene editing with CRISPR, rAAV, and ZFN technologies. Learn more about these approaches and how they can be used to engineer your cell line. (If you're having trouble viewing the video, click here.)
For more on CRISPR, be sure to check out "CRISPR Gene Editing: It Isn't Quite As Easy As It Looks", "CRISPR Case Study: Knockout of Two Genes in a Triploid Cell Line", and "Technical Note: Potential to Supercharge CRISPR Gene Editing by Combining with rAAV".